Tumba, NLNaicker, PrevinStoychev, Stoyan HKillick, MAOwen, GRPapathanasopoulos, MA2022-11-062022-11-062022-07Tumba, N., Naicker, P., Stoychev, S.H., Killick, M., Owen, G. & Papathanasopoulos, M. 2022. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics. <i>Biochemical and Biophysical Research Communications, 612.</i> http://hdl.handle.net/10204/125090006-291X1090-2104https://doi.org/10.1016/j.bbrc.2022.04.101doi: 10.1016/j.bbrc.2022.04.101.http://hdl.handle.net/10204/12509The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) mediates host cell infection by binding to the cellular receptor CD4. Recombinant Env bound to CD4 has been explored for its potential as an HIV vaccine immunogen as receptor binding exposes otherwise shielded, conserved functional sites. Previous preclinical studies showed an interchain disulphide linkage facilitated between Env and 2dCD4S60C generates an immunogenic complex that elicits potent, broadly neutralizing antibodies (bNAbs) against clinically relevant HIV-1. This study investigated conformational dynamics of 2dCD4WT and 2dCD4S60C bound to an HIV-1C SOSIP.664 Env trimer using hydrogen-deuterium exchange mass spectrometry. The Env:2dCD4S60C complex maintains key contact residues required for MHCII and Env/gp120 binding and the residues encompassing Ibalizumab's epitope. Important residues remaining anchored, with an increased flexibility in surrounding regions, evidenced by the higher exchange seen in flanking residues compared to Env:2dCD4WT. While changes in Env:2dCD4S60C dynamics in domain 1 were moderate, domain 2 exhibited greater variation. Lack of stability-inducing H-bonds in these allosteric sites suggest the improved immunogenicity of Env:2dCD4S60C result from exposed CD4 residues providing diverse/novel antigenic targets for the development of potent, broadly neutralizing Ibalizumab-like antibodies.AbstractenCluster of differentiation 4HIV-1 subtype C SOSIP.664 trimerHIV-1 vaccine immunogenHydrogen-deuterium exchangeProtein dynamicsCovalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamicsArticleTumba, N., Naicker, P., Stoychev, S. H., Killick, M., Owen, G., & Papathanasopoulos, M. (2022). Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics. <i>Biochemical and Biophysical Research Communications, 612</i>, http://hdl.handle.net/10204/12509Tumba, NL, Previn Naicker, Stoyan H Stoychev, MA Killick, GR Owen, and MA Papathanasopoulos "Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics." <i>Biochemical and Biophysical Research Communications, 612</i> (2022) http://hdl.handle.net/10204/12509Tumba N, Naicker P, Stoychev SH, Killick M, Owen G, Papathanasopoulos M. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics. Biochemical and Biophysical Research Communications, 612. 2022; http://hdl.handle.net/10204/12509.TY - Article AU - Tumba, NL AU - Naicker, Previn AU - Stoychev, Stoyan H AU - Killick, MA AU - Owen, GR AU - Papathanasopoulos, MA AB - The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) mediates host cell infection by binding to the cellular receptor CD4. Recombinant Env bound to CD4 has been explored for its potential as an HIV vaccine immunogen as receptor binding exposes otherwise shielded, conserved functional sites. Previous preclinical studies showed an interchain disulphide linkage facilitated between Env and 2dCD4S60C generates an immunogenic complex that elicits potent, broadly neutralizing antibodies (bNAbs) against clinically relevant HIV-1. This study investigated conformational dynamics of 2dCD4WT and 2dCD4S60C bound to an HIV-1C SOSIP.664 Env trimer using hydrogen-deuterium exchange mass spectrometry. The Env:2dCD4S60C complex maintains key contact residues required for MHCII and Env/gp120 binding and the residues encompassing Ibalizumab's epitope. Important residues remaining anchored, with an increased flexibility in surrounding regions, evidenced by the higher exchange seen in flanking residues compared to Env:2dCD4WT. While changes in Env:2dCD4S60C dynamics in domain 1 were moderate, domain 2 exhibited greater variation. Lack of stability-inducing H-bonds in these allosteric sites suggest the improved immunogenicity of Env:2dCD4S60C result from exposed CD4 residues providing diverse/novel antigenic targets for the development of potent, broadly neutralizing Ibalizumab-like antibodies. DA - 2022-07 DB - ResearchSpace DP - CSIR J1 - Biochemical and Biophysical Research Communications, 612 KW - Cluster of differentiation 4 KW - HIV-1 subtype C SOSIP.664 trimer KW - HIV-1 vaccine immunogen KW - Hydrogen-deuterium exchange KW - Protein dynamics LK - https://researchspace.csir.co.za PY - 2022 SM - 0006-291X SM - 1090-2104 T1 - Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics TI - Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics UR - http://hdl.handle.net/10204/12509 ER -26038